Optibiotix Health Share Discussion Threads

[elrico] 05/9/2017 12:09

Todays announcement poses a question about TATA's recent launch of its own GOS related healthy option foods containing Fossence™ (Fructo-Oligosaccharide) is a 100 percent soluble, naturally sweet, prebiotic dietary fiber widely used for sugar replacement, fiber fortification with prebiotic properties, as highlighted by Parob, earlier. It appears OPTI's LP-LDL (LPGOS) superior health benefits and TATA may be looking to replace Fossence™ for OPTI's LP-LDL (LPGOS). TATA already have a wide range of food products containing Fossence™ and I guess with a greatly increased margin (already high) post the SACCO deal, I would imagine the new deal with SACCO give OPTI a much more competitive edge on pricing and supply of raw ingredient, not to mention a superior functionality.

Watch this space

[trotterstrading] 05/9/2017 11:26

Announcements stacking up In the background, I think we can expect 3/4 RNS every month now until Xmas. Nice

[jestercat2] 05/9/2017 11:17

Fingers crossed - bit of a Mexican standoff at the mo!

[marnewton] 05/9/2017 11:13

It will...and some;¬)

I'm looking at 83.00/85.00p.

M

[jestercat2] 05/9/2017 10:59

Marnewton - I reckon if 75p goes then the run up to 80p will be fairly swift - we'll see.

[marnewton] 05/9/2017 10:34

75.00p is probably one of our strongest areas of resistance. There's a lot going on here, not least the 50% Fib retracement (log scale).

M

[onedayrodders] 05/9/2017 10:23

running scared on the bid for some reason

[elrico] 05/9/2017 10:14

Just for you Rayrac - Independent studies were presented at international conferences including Hong Kong, Berlin, and the most recent at Budapest by leading Key opinion leaders providing the science on this. These publications go through an external scientific peer review process by experts in the field before publication. Look up Prof Bob Rascal and Professor Glen Gibson, they are world key opinion leaders.

Reading Uni

Conclusions
A systematic approach was used to select a probiotic, L. plantarum LP-LDL®, targeting cholesterol reduction. Using b-galactosidases expressed by L. plantarum LP-LDL® we achieved the synthesis of
GOS that works in true synergy with the parent strain, not only increasing its population but also impacting on the biological activity the probiotic was selected for. THIS IS THE FIRST TIME TRUE SYNERGY IS DEMONSTRATED FOR A SYMBIOTIC IN FAECAL CULTURE. Unquote; that would be a World FIRST, NOT first from scientists at Reading Uni.

Study Highlights
Selecting a probiotic to target a specific health biomarker and using its enzymatic artillery to generate GOS, resulted in the formulation of a true synergistic synbiotic enhancing:
• Lactobacillus concentrations
• BSH and cholesterol reduction activity

This creates the potential for a new concept: a combination of a targeted pre & probiotic called OptiBiotic.

[marnewton] 05/9/2017 10:12

We've already moved above the body of my supposed flag...a high volume breach of recent highs would clinch it.

M

[riskybusiness1] 05/9/2017 10:08

There's a pretty significant possibility Opti are working over a distribution deal for LPLDL with TATA too. LPGOS as well as an cholesterol reducing ingredient in its own right enhances the efficacy of LPLDL when combined. This announcement should hopefully bring the wider markets attention to what Opti are building here and the sheer scale of each area.

[elrico] 05/9/2017 10:01

Glen - the answer to your question is in the todays RNS.

Shrewdmole - Your point about building a £40 million business and not repeating the same mistake is covered in the Q&A. OPTI have a very switched CEO that has the ability to look at his mistakes and learn from them. Though I would wager he makes very few mistakes.

[elrico] 05/9/2017 09:53

I'm hoping the Q&A transcript will be ready for posting this evening, or early AM. However, I could have speeded things up a tad if SOH had given me the heads up on TATA. :)

Instead, I only have more questions ;)

[parob] 05/9/2017 09:46

Moving closer and closer to that 'golden cross'. TW will no doubt give this a mention on HSR giving it an extra boost.

[onedayrodders] 05/9/2017 09:42

RayRac .. please inform TATA immediately that they don't know what they are doing.
After all WTF are TATA anyway ? ...

Tata Chemicals Limited ("TCL" or "Tata Chemicals"), is a global science company active in industrial chemicals, food and nutrition, and agriculture business, and is listed on the Indian stock Exchange. It is part of the Tata Group of Companies which employs over 660,000 employees with annual revenues in 2015/16 of $103.51 billion


;o))

[neftanikoff] 05/9/2017 09:41

A poster called Kipper mentioned a stock yesterday, a new IPO, DESTINY PHARMA (DEST), up a about 50p from his posting, now it's m/cap is twice OPTI's at £100M and revenues years away, but because it is NOT being promoted by share prophets, etc.,then the likes of michaelmouse will not touch it.

[glennrcharles] 05/9/2017 09:37

Do we have any dates for the pilot trial?

[elrico] 05/9/2017 09:29

It would appear we have another "guru" apparently unable to see wood for the tree's. The evidence for effectiveness of the science is available if you had the mind to do a little leg work instead of a blinkered view of a company that has time and again demonstrated the ability to sign multiple formulation, multiple ingredients deals in multiple territories without the need for capex, costs to itself, while in a position where there are several more deals in the pipeline, all of which will be throwing off cash much sooner than we think and all while the cost base is a mere £75k pm. If you don't see value in a company like OPTI, then I have to ask how on earth are you going to make serious headway in managing your investments successfully?

This is one of the big announcements we have been waiting for, but it will be tempered by the "pilot trial" because again, some will be thinking more short term than the long game, which is where the material gains are.

[riskybusiness1] 05/9/2017 09:28

That's equivalent to a phase 2 pharmaceutical trial on LPLDL done independently of Opti by world leading researchers in this space. We do need larger scale studies e.g 150 - 200 but this will come and turn opti in to a whole new animal. LPGOS has only gut model studies though these tend to be almost identical to human trials as the results from LPLDL has shown. Opti are building an evidence base using independent world renowned scientists. First in labs e.g test tube, second in gut models third in human trials then next larger scale trials. If these all replicate Opti have a very strong clinical evidence base for this new science. This is one of the reasons why Opti is not an overnight punt.

[shrewdmole] 05/9/2017 09:19

as for control, ive said it several times, soh sold his last business to 3m and lost control of the product roll out.

he wont do that again hence all deals are pretty much on his terms!

[adnanwolf] 05/9/2017 09:12

The study by Prof Gibson at Reading University was a double blind placebo controlled randomised study!!Adnan

[asterix96] 05/9/2017 09:12

TT. Just filter the idiot!

[trotterstrading] 05/9/2017 09:07

Sure, because multi-nationals like Sacco and TATA are not bothered about efficiency, prob did zero DD on the technology before strike GLOBAL deals. Lol

[rayrac] 05/9/2017 09:04

Show me how effective, there are no controls or evidence of the products working. I'll leave you to find some!

[someuwin] 05/9/2017 08:58

Rayrac - they're not doing phased trials because they're not developing pharmaceuticals (yet).

These are food ingredients and suppleiments which have much lower regulatory requirements.

Even so, the scientific studies and tests performed shows them to be highly efective.